OMERS Administration Corp’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

OMERS Administration Corp’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,500	Closed	-$799	–	372
2022 Q4	$799	Hold	12,500	–	–	﹤0.01%	314
2022 Q3	$1K	Hold	12,500	–	–	﹤0.01%	389
2022 Q2	$1K	Hold	12,500	–	–	﹤0.01%	438
2022 Q1	$3K	Hold	12,500	–	–	﹤0.01%	454
2021 Q4	$8K	Hold	12,500	–	–	﹤0.01%	384
2021 Q3	$8K	Buy	+12,500	New	+$9.3K	﹤0.01%	428

OMERS Administration Corp's BIOTW Position: Q1 2023 in Review

OMERS Administration Corp sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 12,500 shares — an estimated $799 sold.

OMERS Administration Corp first reported a position in BIOTW in Q3 2021 and held it in 6 quarters. The position peaked at $8K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

OMERS Administration Corp reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
OMERS Administration Corp sold 12,500 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $799.
OMERS Administration Corp first reported a position in Biotech Acquisition Company Warrant in Q3 2021 and held it in 6 quarters.
OMERS Administration Corp's Biotech Acquisition Company Warrant position peaked at $8K in Q4 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on OMERS Administration Corp's 13F filing for Q1 2023, filed 12 May 2023.